1988
DOI: 10.1007/bf01959294
|View full text |Cite
|
Sign up to set email alerts
|

Etoposide and teniposide

Abstract: Etoposide (VP 16-213) and teniposide (VM 26) are semisynthetic epipodophyllotoxin derivatives active against a variety of tumours. The clinical efficacy has led to an increasing interest in these compounds. This review presents information on the mechanism of action, biochemical pharmacology, bioanalysis, metabolism and pharmacokinetics of etoposide and teniposide.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
8
0

Year Published

1992
1992
2021
2021

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 56 publications
(10 citation statements)
references
References 65 publications
0
8
0
Order By: Relevance
“…Since unmodified PPT is too toxic for use in the treatment of neoplastic diseases in humans, it mainly serves as a precursor for the synthesis of many widely used chemotherapeutic drugs [2][3][4]. In a recent report, PPT was coupled with tumor-targeted nanoparticles for its systemic delivery to multi-drug resistant tumors in animal models [5]; this research has the potential to lead to the direct use of PPT for the future treatment of many human cancers, further increasing the need for a sustainable source of the compound.…”
Section: Introductionmentioning
confidence: 99%
“…Since unmodified PPT is too toxic for use in the treatment of neoplastic diseases in humans, it mainly serves as a precursor for the synthesis of many widely used chemotherapeutic drugs [2][3][4]. In a recent report, PPT was coupled with tumor-targeted nanoparticles for its systemic delivery to multi-drug resistant tumors in animal models [5]; this research has the potential to lead to the direct use of PPT for the future treatment of many human cancers, further increasing the need for a sustainable source of the compound.…”
Section: Introductionmentioning
confidence: 99%
“…Structure-based design is an attractive approach for the epipodophyllotoxin drug class considering that only two closely related clinically useful analogs, teniposide and etoposide phosphate, have been introduced after nearly four decades of drug optimization using a ligand-based approach. Teniposide, a more lipophilic analog of etoposide, was developed as a means to facilitate cellular drug uptake,16, 17 whereas etoposide phosphate is a hydrolysable prodrug of etoposide that was designed to improve the aqueous solubility of the drug 3, 18…”
Section: Introductionmentioning
confidence: 99%
“…Essential steps in the isolation procedure are CH2C12 and XAD-4 extraction and XAD-8 cc followed by Si gel chromatography, using two different mobile phases. The isolated 5-methoxypodophyllotoxin [1] was very pure (>99%) and possessed the desired stereochemical configuration, namely (-)-5methoxypodophyllotoxin [1], The in vitro cytotoxicity of 5-methoxypodophyllotoxin [1] against EAT and HeLa cells was determined and compared with those of podophyllotoxin [3], etoposide [4], teniposide [51, and 5-methoxypodophyllotoxin-4-P-Dglucoside [6], It appeared that 5-methoxypodophyllotoxin [1] has about the same cytotoxic potency as podophyllotoxin [31-Etoposide [4] and teniposide [5] are clinically applied semi-synthetic cytostatics, chemically prepared from the natural lignan, podophyllotoxin [3] (1-3). The total chemical synthesis of [3] is complicated because of the presence of four chiral centers, a rigid trans-lactone, and an axially locked 1-aryl substituent (4).…”
mentioning
confidence: 99%